Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2LHERP® in Patients With Recurrent Orofacial Herpes Infections
NCT04065971Phase 4Recruiting
- Sponsor
- Labo'Life
- Start
- Mar 2020
- Primary completion
- Mar 2027
- Modality
- Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of 2LHERP in herpes simplex (HSV), sponsored by Labo'Life. Started Mar 2020; status: recruiting.
02
Drugs
2LHERP
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on NCT04065971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04065971.